TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Blood loss during operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total leucocyte concentration in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Zurich Claudication Questionnaire physical function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning basic surgical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of patients treated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of plaques cleared
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LC mortality reduction
Endpoint domain: Mortality/survival
Primary endpoint: overall mortality reduction
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of NMIP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood transfusions during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CPB hemodilution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion (ROM) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HSS score increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: finger-pinch force control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: finger-pinch force variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: targeting error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulmonary functional excellent rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence rates of adverse side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Increased usage of blood transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Development of CDMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: New brain lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: on-treatment virological milestones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall sexual satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: satisfaction with sexual life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall operative mortality
Endpoint domain: Mortality/survival
Primary endpoint: pain interference severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of use of contraceptive implant at 3 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of use of contraceptive implant at 12 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from posttraumatic stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder pain incidence
Endpoint domain: Adverse events/effects
Primary endpoint: IKDC, Tegner, and Lysholm scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ECV success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maternal pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful induction of ventricular fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic error rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aesthetic quality score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: problem distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: pain rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coagulation area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coagulation times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: local recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Diabetes risk
Endpoint domain: Mortality/survival
Primary endpoint: Prevalent microvascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma branched perfluorooctanoic acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BI response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQL decline on emotional scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HRQL decline on mental component score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma adiponectin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infection rate of S. japonicum
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic accuracy for early gastric cancer and precancerous lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: reduction in platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: increase in IPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: decrease in fibrinogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: cognitive outcome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Tissue acquisition speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specimen retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specimen quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: embryonic grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: renal inositol excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Concomitant use of prescription drugs and dietary supplements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total nasal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: urinary ACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum chloride concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strong ion difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of weekly mean pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: URI incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Tinetti test score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle performance from Sit-To-Stand tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls recorded during follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of second stage of labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometritis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Significant blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Symptom level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to work (RTW) rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: H. pylori eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Knee related function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superinfection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of antibiotic days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient activation scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Probability of repeat biopsy within 3 years
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of controlled subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe disability at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy of car seat installation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: harmful alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: JADAS-27 disease activity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroprotection rates for measles, mumps, and rubella
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody concentrations against measles, mumps, and rubella
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean serum folate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean erythrocyte folate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health Anxiety Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Telomerase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of macrosomia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of fetal distress
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of neonatal metabolic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Intent to use synthetic cannabis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Estimated glomerular filtration rate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: percentage time with intraesophageal pH <4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neutropenia frequency
Endpoint domain: Adverse events/effects
Primary endpoint: lesion detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in stressful neurobehavioural signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PON1 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in percentage of predicted FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in percentage of FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in dyspnoea
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum concentrations of cefuroxime above MIC90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cefuroxime detection in middle ear effusion samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative survival rate of IRC onlays
Endpoint domain: Mortality/survival
Primary endpoint: HAI titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody avidity (AI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cognitive dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: overall activity level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Volumetric increase of cerebral cortical gray
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: dropout rate due to adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: chair rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: salivary cortisol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Relapse to regular heroin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood naltrexone levels below 2 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trial-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: cerebral blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Disease Activity Score in 28 joints remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Assessment Questionnaire Disability Index improvement ≥0.3
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adjusted mean UPDRS Parts II + III scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: integrative scores of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean depth of wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of enamel worn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of angioedema
Endpoint domain: Adverse events/effects
Primary endpoint: Retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Effectiveness of non-surgical periodontal treatment to slow CKD progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Airway neutrophilia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: LPS-induced IL-1β, IL-6, and IL-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: ICAM-1 expression in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: LFA-1 expression in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increased risk of CRM involvement
Endpoint domain: Mortality/survival
Primary endpoint: Increased LR rate
Endpoint domain: Mortality/survival
Primary endpoint: Decreased CSS rate
Endpoint domain: Mortality/survival
Primary endpoint: mACR20(3 of 4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: tPRI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Psychiatric Rating Scale change score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: postoperative voiding dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Monocyte tissue factor expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: improvements in outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RF applications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean level of burden on relatives
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Incidence of acute adverse reactions to antivenom serum
Endpoint domain: Adverse events/effects
Primary endpoint: Recall score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: sugar intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QALY saved
Endpoint domain: Mortality/survival
Primary endpoint: DALY averted
Endpoint domain: Mortality/survival
Primary endpoint: regress of morphofunctional alterations associated with LV remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Enhancement features of SHCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of severe relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annualized relapse rate (ARR) for severe relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapses affecting activities of daily living
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postexposure state anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of all-cause hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Length of stay for all-cause hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction in sales of unhealthy snacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pH levels at 2-mm and 5-mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for acid regurgitation and heartburn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge and confidence mean scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: grade 3 or 4 fatigue
Endpoint domain: Adverse events/effects
Primary endpoint: grade 3 or 4 leukopenia
Endpoint domain: Adverse events/effects
Primary endpoint: grade 3 or 4 GI toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Patient pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complications' incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Conversion to sinus rhythm within 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients calling for emergency room assistance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decreased SpO2 AUC < 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with SpO2 < 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of SpO2 < 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of heavy drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craving scores (Hamilton Anxiety Rating Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average increase in technetium‐99m methylene diphosphonate uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radio-opacity measured by Image J programme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-stent late loss at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma beta-hydroxybutyrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transcutaneous bilirubin levels below 10 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of recurrence of goitre
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SLST score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FUT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of NEC stage III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction of suicidal behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of hospitalisation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Distance walked in 12MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stairs climbed per minute in 3MSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: long-term cocaine abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of patients achieving primary outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes